Stephen A. Ross serves as Executive at CYTOGEN CORP, where they oversee executive responsibilities. Since joining the company, Stephen A. Ross has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 8, 2008 involved selling 20,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 8, 2008 | CYTO | $0 | Disposition | 20,000 | $N/A | Discretionary |
Stephen A. Ross currently holds 0 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen A. Ross has been a net neutral trader of CYTO stock. They have purchased $0 and sold $0 worth of shares.
Stephen A. Ross's most recent insider trade was on May 8, 2008, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted